With the growing prevalence of artificial intelligence (AI), demand increases for hardware that mimics the brain’s ability to ...

On September 1, 2026, medical device company DermaSensor Inc. announced four new industry partnerships. DermaSensor is focused on early detection ...

Imagine you’re getting out of the shower one morning and you notice a mole on your thigh that you’ve never seen before. It’s reddish brown, bumpy and surprisingly large. Is it a benign mole, or is it ...

New AI tools used in dermatology have a crucial shortcoming. Imagine you’re getting out of the shower one morning and you notice a mole on your thigh that you’ve never seen before. It’s reddish brown, ...

An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more effective at predicting ...

An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new ...

Moderna is touting a "landmark moment" in its experimental melanoma treatment, saying its vaccine could help prevent the deadly skin cancer from returning or spreading. The groundbreaking clinical ...

Merck MRK.N and Moderna MRNA.O said on Wednesday a study of a personalized mRNA vaccine combined with the immunotherapy drug Keytruda reduced melanoma skin cancer recurrence and spread compared with ...

The trial only included people with melanoma, but experts say the same treatment approach could potentially be applied more broadly—to other types of cancer, as well as rare conditions caused by ...

Moderna and Merck say the experimental vaccine prevented the return and spread of the cancer in high-risk melanoma patients. By Carolyn Y. Johnson An experimental mRNA vaccine allowed people with high ...